Showing results (451-460 of 682) with videos related to

Sort By:
Pageof 69
Cancer Chemotherapy and Pharmacology|January 1, 1988
Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatinP A Steerenberg, C P Vendrik, W H de Jong, et al.
Experimental Cell Research|January 1, 1986
Reconstitution of the vascular wall in vitro. A novel model to study interactions between endothelial and smooth muscle cellsM F van Buul-Wortelboer, H J Brinkman, K P Dingemans, et al.
Gastroenterology|July 5, 2001
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysisT Lisman, F W Leebeek, L O Mosnier, et al.
Blood|September 23, 2008
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patientsAugusto B Federici, Pier M Mannucci, Giancarlo Castaman, et al.
Blood|April 1, 1988
Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF)A B Federici, C De Romeuf, P G De Groot, et al.
Blood|December 1, 1995
On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing bloodS C Endenburg, R R Hantgan, L Lindeboom-Blokzijl, et al.
Thrombosis Research|December 18, 2003
Increased high molecular weight fibrinogen in pre-eclampsiaG T R Manten, J M Sikkema, A Franx, et al.
Thrombosis and Haemostasis|October 21, 1986
von Willebrand factor in cultured human vascular endothelial cells from adult and umbilical cord arteries and veinsP B van Wachem, J H Reinders, M F van Buul-Wortelboer, et al.
The Journal of Biological Chemistry|November 9, 2014
Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin NetworkAdam Miszta, Leonie Pelkmans, Theo Lindhout, et al.
Human Toxicology|January 1, 1986
Haemoperfusion: a useful therapy for a severely poisoned patient?M E De Broe, C Bismuth, G De Groot, et al.
Pageof 69